Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era.

CONCLUSIONS: We developed risk scores to predict CSS for patients treated with CN in the contemporary era. Patients with poor predicted survival may consider avoiding CN as initial management. PMID: 30228096 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30228096?dopt=Abstract

Source: Urologic Oncology - September 15, 2018 Category: Urology & Nephrology Authors: Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC Tags: Urol Oncol Source Type: research